Search

everythinglearnresearchcommunity

for

Search:↓

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Mouse embryos can develop in chick embryos, but they grow smaller with some organ issues.

Minoxidil and Finasteride are the most popular hair loss treatments, with rising interest in other options, and economic or health crises can change what treatments people prefer.

Granules improve hair loss treatment by targeting follicles.

Dialysis patients benefit from water-soluble vitamins but need careful management to avoid risks.

Eosinophilia-myalgia syndrome, linked to contaminated L-tryptophan supplements, caused severe symptoms and some deaths, with long-term effects in survivors.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

AGA is a genetic, hormonal hair loss treated with finasteride, minoxidil, and supplements, but new compounds are being developed.

Cosmetic foam product reduces hair loss and increases hair density in men.

Neuroactive steroids may affect the risk and treatment of alcohol use disorders.

Three Indian medicinal plant compounds help hair growth.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Vitamins A, B3, C, D, and E can improve skin health and immunity.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Microtechnology methods improve organoid production for medical research.

Microneedles improve drug delivery in various body parts, are safe and painless, and show promise in cosmetology, vaccination, insulin delivery, and other medical applications.

Substances from Chinese medicines show promise for immune support and disease prevention, but the way they are processed affects their effectiveness.

Hair analysis can detect drug use but requires careful interpretation due to its complexity.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

Engineered extracellular vesicles show promise for targeted therapy but need more research for clinical use.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

St. John's wort increases finasteride metabolism, reducing its effectiveness; use caution when combining them.

Optimized film improves finasteride skin absorption and treatment efficiency.

Prenatal stress changes how male and female rats enjoy rewards differently, linked to sex hormones.

Some chemicals absorbed through the skin can cause serious health problems.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

lncRNAs may regulate hair follicle development in Hu sheep.